Monitoring 14-3-3 protein interactions with a homogeneous, fluorescence polarization assay

被引:31
作者
Du, YH
Masters, SC
Khuri, FR
Fu, H [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
[2] Emory Univ, Emory Chem Biol Discovery Ctr, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA
关键词
14-3-3; fluorescence polarization; protein-protein interaction;
D O I
10.1177/1087057105284862
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The 14-3-3 proteins mediate phosphorylation-dependent protein-protein interactions. Through binding to numerous client proteins, 14-3-3 controls a wide range of physiological processes and has been implicated in a variety of diseases, including cancer and neurodegenerative disorders. To better understand the Structure and function of 14-3-3 proteins and to develop small-molecule modulators of 14-3-3 proteins for physiological studies and potential therapeutic interventions, the authors have designed and optimized a highly sensitive fluorescence polarization (FP)-based 14-3-3 assay. Using the interaction of 14-3-3 with a fluorescently labeled phosphopeptide frorn Raf- I asa model system, they have achieved a simple I -step "Illixand-i-neasure" method for analyzing 14-3-3 proteins. This is a solution-based, versatile method that can be used to monitor the binding of 14-3-3 with a variety of client proteins. The 14-3-3 FP assay is highly stable and has achieved a robust performance in a 384-well format with a demonstrated signal-to-noise ratio greater than 10 and a Z' factor greater than 0.7. Because of its simplicity and high sensitivity, this assay is generally applicable to studying 14-3-3/client-protein interactions and especially valuable for high-throughput screening of 14-3-3 modulators.
引用
收藏
页码:269 / 276
页数:8
相关论文
共 35 条
[1]   Specificity of 14-3-3 isoform dimer interactions and phosphorylation [J].
Aitken, A ;
Baxter, H ;
Dubois, T ;
Clokie, S ;
Mackie, S ;
Mitchell, K ;
Peden, A ;
Zemlickova, E .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :351-360
[2]   Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream [J].
Arkin, MR ;
Wells, JA .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :301-317
[3]  
Ausubel F.M., 1994, CURRENT PROTOCOLS MO
[4]   Fluorescence polarization assays for high throughput screening of G protein-coupled receptors [J].
Banks, P ;
Gosselin, M ;
Prystay, L .
JOURNAL OF BIOMOLECULAR SCREENING, 2000, 5 (03) :159-167
[5]   Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1 [J].
Chen, HK ;
Fernandez-Funez, P ;
Acevedo, SF ;
Lam, YC ;
Kaytor, MD ;
Fernandez, MH ;
Aitken, A ;
Skoulakis, EMC ;
Orr, HT ;
Botas, J ;
Zoghbi, HY .
CELL, 2003, 113 (04) :457-468
[6]   Unlocking the code of 14-3-3 [J].
Dougherty, MK ;
Morrison, DK .
JOURNAL OF CELL SCIENCE, 2004, 117 (10) :1875-1884
[7]   14-3-3 proteins: regulation of signal-induced events [J].
Ferl, RJ .
PHYSIOLOGIA PLANTARUM, 2004, 120 (02) :173-178
[8]   Small molecule inhibitors of p53/MDM2 interaction [J].
Fotouhi, N ;
Graves, B .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) :159-165
[9]   THE EUKARYOTIC HOST FACTOR THAT ACTIVATES EXOENZYME-S OF PSEUDOMONAS-AERUGINOSA IS A MEMBER OF THE 14-3-3 PROTEIN FAMILY [J].
FU, H ;
COBURN, J ;
COLLIER, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) :2320-2324
[10]   14-3-3 proteins: Structure, function, and regulation [J].
Fu, HA ;
Subramanian, RR ;
Masters, SC .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :617-647